Ibrolipim (C007B-202878)

Lipoprotein Lipase Activator is a cell-permeable benzylphosphonate derivative that selectively induces lipoprotein lipase (LPL) mRNA and protein levels, but does not exhibit PPARα or PPARγ agonistic activities. Lipoprotein Lipase Activator lowers serum lipid levels and plasma triglycerides with concomitant elevation in high-density lipoprotein cholesterol (HDL-C) in animal models. Lipoprotein Lipase Activator also induces fatty acid oxidation related enzymes, lowers free fatty acids (FFA), and minimizes fat accumulation. Also reported to suppress the plasma levels of TNF-a and COX-2 and displays anti-tumor properties. Specification: ≥95% Molecular Formula: C19H20BrN2O4P Molecular Weight: 451.25 PubChem CID: 131601 Isomeric SMILES: CCOP(=O)(CC1=CC=C(C=C1)C(=O)NC2=C(C=C(C=C2)Br)C#N)OCC Related Documents: https://ald-pub-files.oss-cn-shanghai.aliyuncs.com/aladdinsci/pdp/sds/1/L339156-SCI_bd31aa2d39972e556d05eeb4986a6c41.pdf

UPC:

51322503

Condition:

New

Weight:

1.06 Ounces

HazmatClass:

No

Quantity:

1

Unit of Measurement:

EA

WeightUOM:

LB

MPN:

L339156-100mg

CAS:

133208-93-2

Product Size:

100mg

Hazard Statement Codes:

H315:H319:H335

Precautionary Statement Codes:

P261:P264:P271:P280:P302+P352:P304+P340:P305+P351+P338:P362+P364:P405:P403+P233:P501